EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes

Xu Teng, Tianshu Yang, Baowen Yuan, Yunkai Yang, Jiaxiang Liu, Xin Wang, Yong Wang, Tianyu Ma, Xin Yin, Hefen Yu, Shuang Wang, Wei Huang

Frontiers in Oncology · 07.06.2023 · 13

DOI: 10.3389/fonc.2023.1177133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 07.06.2023. Verfasst von Xu Teng und 11 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer has a high tumor-specific death rate and poor prognosis. In this study, we aimed to provide a basis for the prognostic risk in patients with breast cancer using significant gene sets selected by analyzing tumor mutational burden (TMB) and DNA damage repair (DDR).

Methods

Breast cancer genomic and transcriptomic data were obtained from The Cancer Genome Atlas (TCGA). Breast cancer samples were dichotomized into high- and low-TMB groups according to TMB values. Differentially expressed DDR genes between high- and low-TMB groups were incorporated into univariate and multivariate cox regression model to build prognosis model. Performance of the prognosis model was validated in an independently new GEO dataset and evaluated by time-dependent ROC curves.

Results

Between high- and low-TMB groups, there were 6,424 differentially expressed genes, including 67 DDR genes. Ten genes associated with prognosis were selected by univariate cox regression analysis, among which seven genes constituted a panel to predict breast cancer prognosis. The seven-gene prognostic model, as well as the gene copy numbers are closely associated with tumor-infiltrating immune cells.

Conclusion

We established a seven-gene prognostic model comprising MDC1 , PARP3 , PSMB1 , PSMB9 , PSMD2 , PSMD7 , and PSMD14 genes, which provides a basis for further exploration of a population-based prediction of prognosis and immunotherapy response in patients with breast cancer.

Schlagwörter

Stichwörter der Autor:innen

Cox-LASSO regression analysisTMBbreast cancercox regression analysisprognostic modeltumor-infiltrating immune cells

Autor:innen und Institutionen

  • Beijing Key Laboratory of Cancer Invasion and Metastasis Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • Key Laboratory of Cancer and Microbiome, State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Un…
  • Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Ultrasound, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Department of Cardio Surgery Center, Shandong Second Provincial General Hospital, Jinan, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Teng, X., Yang, T., Yuan, B., Yang, Y., Liu, J., Wang, X., Wang, Y., Ma, T., Yin, X., Yu, H., Wang, S., & Huang, W. (2023). Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1177133

Vancouver

Teng X, Yang T, Yuan B, Yang Y, Liu J, Wang X, et al. Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1177133

BibTeX
@article{Teng2023,
  author = {Teng, Xu and Yang, Tianshu and Yuan, Baowen and Yang, Yunkai and Liu, Jiaxiang and Wang, Xin and Wang, Yong and Ma, Tianyu and Yin, Xin and Yu, Hefen and Wang, Shuang and Huang, Wei},
  title = {Prognostic analysis of patients with breast cancer based on tumor mutational burden and DNA damage repair genes},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1177133}
}
Kostenlos starten →